Literature DB >> 22763314

Transvaginal single-port natural orifice transluminal endoscopic surgery for benign uterine adnexal pathologies.

Ki Hoon Ahn1, Jae Yun Song, Sun Haeng Kim, Kyu Wan Lee, Tak Kim.   

Abstract

Transvaginal natural orifice transluminal endoscopic surgery (NOTES) with pneumoperitoneum has been used in cholecystectomies, appendectomies, and nephrectomies, but transvaginal NOTES using a single port in gynecologic procedures has not been described despite gynecologist familiarity with the vaginal approach. We performed transvaginal single-port NOTES in 10 women with benign uterine adnexal disease: oophorectomy in 3 patients, salpingostomy and salpingectomy in 2 each, and ovarian cystectomy, paratubal cystectomy, and ovarian wedge resection in 1 each. The patients were discharged at 1 or 2 days postoperatively, and were satisfied, with minimal pain, no abdominal scar, and no complications at 2-month follow-up. We conclude that transvaginal single-port NOTES to treat benign uterine adnexal disease is a feasible and attractive option.
Copyright © 2012 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22763314     DOI: 10.1016/j.jmig.2012.04.001

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  9 in total

1.  Hysterectomy via transvaginal natural orifice transluminal endoscopic surgery for nonprolapsed uteri.

Authors:  Chin-Jung Wang; Hui-Yu Huang; Chen-Ying Huang; Hsuan Su
Journal:  Surg Endosc       Date:  2014-10-01       Impact factor: 4.584

2.  Natural orifice transluminal endoscopic surgery-assisted versus laparoscopic ovarian cystectomy (NAOC vs. LOC): a case-matched study.

Authors:  Chin-Jung Wang; Pei-Yin Wu; Hsin-Hong Kuo; Hsing-Tse Yu; Chen-Ying Huang; Hsiao-Tseng Tseng
Journal:  Surg Endosc       Date:  2015-07-03       Impact factor: 4.584

3.  The Feasibility of Natural Orifice Transluminal Endoscopic Surgery in Gynecology Practice: Single-Surgeon Experience.

Authors:  Cihan Kaya; Ismail Alay; Sukru Yildiz; Huseyin Cengiz; Xalide Afandi; Levent Yasar
Journal:  Gynecol Minim Invasive Ther       Date:  2020-04-28

4.  Postoperative outcomes of natural orifice transluminal endoscopic surgery-assisted vaginal hysterectomy and conventional laparoscopic-assisted vaginal hysterectomy: a comparative study.

Authors:  Seong Hee Kim; Chan Hee Jin; In Taek Hwang; Jun Sook Park; Jung Hwan Shin; Dae Woon Kim; Yong Soo Seo; Jee Nah Sohn; Yun Seok Yang
Journal:  Obstet Gynecol Sci       Date:  2018-02-19

5.  Use of human fibrin glue (Tisseel) versus suture during transvaginal natural orifice ovarian cystectomy of benign and non-endometriotic ovarian tumor: a retrospective comparative study.

Authors:  Yu-Ying Su; Yu-Shan Lin; Lan-Yan Yang; Yu-Bin Pan; Yi-Ting Huang; Cindy Hsuan Weng; Kai-Yun Wu; Chin-Jung Wang
Journal:  BMC Surg       Date:  2021-01-21       Impact factor: 2.102

6.  Comparison of Surgical Outcomes of Hysterectomy by Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) versus Single-Port Access (SPA) Surgery.

Authors:  Joseph J Noh; Myeong-Seon Kim; Jun-Hyeok Kang; Ji-Hee Jung; Chi-Son Chang; Jungeun Jeon; Tae-Joong Kim
Journal:  J Pers Med       Date:  2022-05-26

7.  Hysterectomy and salpingo-oophorectomy by transvaginal natural orifice transluminal endoscopic surgery (V-NOTES) assisted by an umbilical camera: Case report and new hybrid technique in gynecology.

Authors:  Hasan Terzi; Unal Turkay; Navdar Dogus Uzun; Mehmet Salıcı
Journal:  Int J Surg Case Rep       Date:  2018-09-05

Review 8.  Review of transvaginal natural orifice transluminal endoscopic surgery in gynecology.

Authors:  Naoyuki Yoshiki
Journal:  Gynecol Minim Invasive Ther       Date:  2017-01-20

9.  Comparison of Transvaginal and Transumbilical Laparoscopic Single-Site Surgery for Ovarian Cysts.

Authors:  Chunhua Zhang; Kristina Duan; Fang Fang; Ling Wu; Quinn Xu; Stephanie Delgado; Fuxue Shu; Linyi Hu; Xiaoming Guan
Journal:  JSLS       Date:  2021 Apr-Jun       Impact factor: 2.172

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.